终结艾滋病大流行。
Ending the HIV/AIDS Pandemic.
出版信息
Emerg Infect Dis. 2018 Mar;24(3):413-416. doi: 10.3201/eid2403.171797.
Abstract
The goal of ending the HIV/AIDS pandemic is theoretically achievable and would require addressing this global health catastrophe on individual and global levels by providing optimal prevention strategies and treatment regimens for individual persons living with or at risk for HIV, as well as ending the pandemic as an epidemiologic and global health phenomenon. However, from a practical standpoint, the pathway to ending the HIV/AIDS pandemic will be difficult and will require aggressive implementation of the biomedical research advances that have been made in the areas of treatment and prevention; development of additional tools, such as a moderately effective HIV vaccine; and attention to critical behavioral and social determinants. An end to the HIV/AIDS pandemic can be achieved only with provision of sustained and additional resources at the local, regional, national, and global levels.
摘要
终结艾滋病大流行的目标在理论上是可行的，需要通过为每一位艾滋病毒感染者或有感染风险的人提供最佳的预防策略和治疗方案，以及终结艾滋病作为一种流行病学和全球健康现象，在个人和全球层面上应对这一全球卫生灾难。然而，从实际的角度来看，终结艾滋病大流行的道路将是艰难的，需要积极实施在治疗和预防领域取得的生物医学研究进展；开发其他工具，如一种中等有效的 HIV 疫苗；并关注关键的行为和社会决定因素。只有在地方、区域、国家和全球各级持续提供和增加资源，才能终结艾滋病大流行。
相似文献
1
Ending the HIV/AIDS Pandemic.终结艾滋病大流行。
Emerg Infect Dis. 2018 Mar;24(3):413-416. doi: 10.3201/eid2403.171797.
2
Thirty years of HIV and AIDS: future challenges and opportunities.艾滋病病毒与艾滋病 30 年：未来的挑战与机遇。
Ann Intern Med. 2011 Jun 7;154(11):766-71. doi: 10.7326/0003-4819-154-11-201106070-00345. Epub 2011 May 31.
3
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.一种HIV疫苗对于终结HIV/AIDS大流行至关重要。
JAMA. 2017 Oct 24;318(16):1535-1536. doi: 10.1001/jama.2017.13505.
4
Introduction to the Special Issue: Ending the AIDS Pandemic by 2030: Accelerating Efforts to Prevent HIV.特刊引言：到2030年终结艾滋病流行：加速预防艾滋病毒的努力
AIDS Educ Prev. 2018 Jun;30(3):185-186. doi: 10.1521/aeap.2018.30.3.185.
5
Marking Time in the Global HIV/AIDS Pandemic.在全球艾滋病毒/艾滋病大流行中徘徊不前。
JAMA. 2016 Jul 12;316(2):145-6. doi: 10.1001/jama.2016.9006.
6
Epidemiology, evolution, and future of the HIV/AIDS pandemic.艾滋病大流行的流行病学、演变及未来
Emerg Infect Dis. 2001;7(3 Suppl):505-11. doi: 10.3201/eid0707.017704.
7
Ending the HIV-AIDS Pandemic--Follow the Science.终结艾滋病毒-艾滋病大流行——遵循科学。
N Engl J Med. 2015 Dec 3;373(23):2197-9. doi: 10.1056/NEJMp1502020. Epub 2015 Dec 1.
8
Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal.控制并最终终结艾滋病疫情：一个可行的目标。
JAMA. 2010 Jul 21;304(3):350-1. doi: 10.1001/jama.2010.957.
9
Ending the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits.终结人类免疫缺陷病毒流行：优化预防和治疗工具包。
Clin Infect Dis. 2019 Nov 27;69(12):2212-2217. doi: 10.1093/cid/ciz998.
10
The HIV/AIDS pandemic: a sign of instability in a complex global system.艾滋病毒/艾滋病大流行：复杂全球系统不稳定的一个迹象。
J Med Philos. 2002 Apr;27(2):163-77. doi: 10.1076/jmep.27.2.163.2992.
引用本文的文献
1
Determinants of virological failure among people living with HIV receiving first-line antiretroviral therapy in Hiwot Fana Comprehensive University Hospital, Eastern Ethiopia.埃塞俄比亚东部希沃特法纳综合大学医院接受一线抗逆转录病毒治疗的艾滋病毒感染者病毒学失败的决定因素。
Medicine (Baltimore). 2025 Jul 25;104(30):e43255. doi: 10.1097/MD.0000000000043255.
2
The elimination of HIV/AIDS depends on prevention and treatment strategies that address health inequalities.消除艾滋病毒/艾滋病取决于应对健康不平等问题的预防和治疗策略。
Cad Saude Publica. 2025 Jul 21;41(7):e00106825. doi: 10.1590/0102-311XEN106825. eCollection 2025.
3
Biomedical Interventions for HIV Prevention and Control: Beyond Vaccination.用于艾滋病毒预防和控制的生物医学干预措施：超越疫苗接种
Viruses. 2025 May 26;17(6):756. doi: 10.3390/v17060756.
4
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.结构病毒学：抗病毒治疗药物研发中的关键决定因素
Viruses. 2025 Mar 14;17(3):417. doi: 10.3390/v17030417.
5
Applying the Social Ecological Model to Explore HIV-Related Stigma in Florida: A Qualitative Study.应用社会生态模型探索佛罗里达州与艾滋病相关的耻辱感：一项定性研究。
Stigma Health. 2024 Aug;9(3):362-371. doi: 10.1037/sah0000458. Epub 2023 May 11.
6
Low effective coverage of HIV testing and counselling services during antenatal care in Ethiopia: evidence from the demographic and health survey and service provision assessment.埃塞俄比亚产前护理期间艾滋病毒检测与咨询服务的有效覆盖率较低：来自人口与健康调查及服务提供评估的证据
BMJ Public Health. 2024 Nov 20;2(2):e001158. doi: 10.1136/bmjph-2024-001158. eCollection 2024 Dec.
7
Investigating the effects of cytokine biomarkers on HIV incidence: a case study for individuals randomized to pre-exposure prophylaxis vs. control.研究细胞因子生物标志物对 HIV 发病率的影响：一项针对接受暴露前预防与对照组个体的随机研究。
Front Public Health. 2024 Jun 25;12:1393627. doi: 10.3389/fpubh.2024.1393627. eCollection 2024.
8
Advancing Toward a Human Immunodeficiency Virus Cure: Initial Progress on a Difficult Path.迈向人类免疫缺陷病毒治愈之路：艰难进程中的初步进展。
Infect Dis Clin North Am. 2024 Sep;38(3):487-497. doi: 10.1016/j.idc.2024.06.001. Epub 2024 Jul 4.
9
The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention.广泛中和抗体（bNAbs）在 HIV-1 治疗和预防中的应用。
Viruses. 2024 Jun 4;16(6):911. doi: 10.3390/v16060911.
10
Disparities in mortality trends of adults with HIV in the USA: A comprehensive examination across 2 decades.美国艾滋病毒感染者死亡率趋势的差异：20 年来的综合考察。
Medicine (Baltimore). 2024 Jun 21;103(25):e38570. doi: 10.1097/MD.0000000000038570.
本文引用的文献
1
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic.一种HIV疫苗对于终结HIV/AIDS大流行至关重要。
JAMA. 2017 Oct 24;318(16):1535-1536. doi: 10.1001/jama.2017.13505.
2
Redefining Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis Failures.重新定义人类免疫缺陷病毒（HIV）暴露前预防失败
Clin Infect Dis. 2017 Oct 30;65(10):1768-1769. doi: 10.1093/cid/cix593.
3
90-90-90 and ending AIDS: necessary and feasible.90-90-90与终结艾滋病：必要且可行。
Lancet. 2017 Jul 22;390(10092):341-343. doi: 10.1016/S0140-6736(17)31872-X.
4
Universal antiretroviral regimens: thinking beyond one-pill-once-a-day.通用抗逆转录病毒治疗方案：超越每日一片的思考。
Curr Opin HIV AIDS. 2017 Jul;12(4):343-350. doi: 10.1097/COH.0000000000000374.
5
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.抗逆转录病毒疗法预防HIV-1传播
N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.
6
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.血清学异性性伴侣中，当 HIV 阳性一方接受抑制性抗反转录病毒治疗时，无保护性行为与 HIV 传播风险
JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148.
7
Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care.缩小接受治疗的HIV感染者与未感染HIV个体之间的预期寿命差距。
J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):39-46. doi: 10.1097/QAI.0000000000001014.
8
Ending the HIV-AIDS Pandemic--Follow the Science.终结艾滋病毒-艾滋病大流行——遵循科学。
N Engl J Med. 2015 Dec 3;373(23):2197-9. doi: 10.1056/NEJMp1502020. Epub 2015 Dec 1.
9
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.在曼谷泰国注射吸毒者中预防艾滋病毒感染的抗逆转录病毒预防（曼谷替诺福韦研究）：一项随机、双盲、安慰剂对照的 3 期临床试验。
Lancet. 2013 Jun 15;381(9883):2083-90. doi: 10.1016/S0140-6736(13)61127-7. Epub 2013 Jun 13.
10
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.博茨瓦纳异性传播 HIV 中抗逆转录病毒的预先暴露预防。
N Engl J Med. 2012 Aug 2;367(5):423-34. doi: 10.1056/NEJMoa1110711. Epub 2012 Jul 11.
Zotero 插件